Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions

Area of Science:

• Cardiology
• Translational Medicine

Background:

• Heart failure (HF) and atrial fibrillation (AF) frequently coexist, creating a complex clinical challenge.
• Both conditions share common risk factors and exhibit a bidirectional pathophysiological relationship.
• Key shared mechanisms include neurohormonal hyperactivation, cardiac fibrosis, and electrophysiological remodeling.

Purpose of the Study:

• To review the current understanding of the pathophysiology linking HF and AF.
• To present novel and emerging treatment strategies for this comorbidity.
• To discuss future perspectives and identify unanswered questions in the management of HF and AF.

Main Methods:

• Literature review of existing scientific publications.
• Synthesis of information on pathophysiological mechanisms.
• Analysis of current and novel therapeutic approaches.

Main Results:

• Established treatments for HF are often applicable to patients with comorbid AF.
• Management of AF involves rate or rhythm control and anticoagulation, using pharmaceutical or non-pharmaceutical methods.
• Shared pathophysiological pathways highlight the interconnectedness of these conditions.

Conclusions:

• The interplay between HF and AF necessitates a comprehensive management approach.
• Further research is crucial to address the numerous unanswered questions regarding their linked pathophysiology and treatment.
• Novel therapeutic trends offer promise for improving outcomes in patients with this challenging comorbidity.